Abstract
Transforming growth factor-β1 (TGF-β1) has been thought to play a major role during cardiac fibrosis in the development of diabetic cardiomyopathy, and cardiac fibrosis mainly as a result of an increase of collagen type III occurs in the human hearts with diabetes. Thrombospondin-1 (TSP-1) has been reported to activate the latent complex of TGF-β1. We examined the effects of TSP-1 on the expression of TGF-β1 and collagen type III by rat cardiac fibroblasts in high ambient glucose. We demonstrated that high glucose induces the mRNA and protein expression of collagen type III, TGF-β1, and TSP-1. Furthermore, the mRNA and protein expression of collagen type III induced by high glucose was downregulated after treatment with TGF-β1 antibody, or TSP-1 siRNA. The expression of TGF-β1 increased by high glucose was also reversed after treatment with TSP-1 siRNA. Our findings suggest that the TSP-1 participates in the upregulation of TGF-β1, collagen type III by high glucose and may provide new therapeutic strategies for diabetic cardiomyopathy.
Similar content being viewed by others
Abbreviations
- TSP-1:
-
Thrombospondin-1
- TGF-β1:
-
Transforming growth factor-β1
References
Hunt SA, Baker DW, Chin MH, Cinquegrani MP, Feldman AM, Francis GS, Ganiats TG, Goldstein S, Gregoratos G, Jessup ML, Noble RJ, Packer M, Silver MA, Stevenson LW, Gibbons RJ, Antman EM, Alpert JS, Faxon DP, Fuster V, Jacobs AK, Hiratzka LF, Russell RO, Smith SC, Jr. (2001) Acc/aha guidelines for the evaluation and management of chronic heart failure in the adult. Journal of the American College of Cardiology 38 (7):2101-2113. doi: 10.1161/hc4901.102568
Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME (2008) Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options. Am J Med 121(9):748–757. doi:10.1016/j.amjmed.2008.03.046
Lago RM, Singh PP, Nesto RW (2007) Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 370(9593):1129–1136. doi:10.1016/S0140-6736(07)61514-1
van Hoeven KH, Factor SM (1990) A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82(3):848–855
Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47(4):693–700. doi:10.1016/j.jacc.2005.09.050
Suskin N, McKelvie RS, Burns RJ, Latini R, Pericak D, Probstfield J, Rouleau JL, Sigouin C, Solymoss CB, Tsuyuki R, White M, Yusuf S (2000) Glucose and insulin abnormalities relate to functional capacity in patients with congestive heart failure. Eur Heart J 21(16):1368–1375. doi:10.1053/euhj.1999.2043
Tang M, Zhang W, Lin H, Jiang H, Dai H, Zhang Y (2007) High glucose promotes the production of collagen types I and III by cardiac fibroblasts through a pathway dependent on extracellular-signal-regulated kinase 1/2. Mol Cell Biochem 301(1–2):109–114. doi:10.1007/s11010-006-9401-6
Pauschinger M, Knopf D, Petschauer S, Doerner A, Poller W, Schwimmbeck PL, Kuhl U, Schultheiss HP (1999) Dilated cardiomyopathy is associated with significant changes in collagen type I/III ratio. Circulation 99(21):2750–2756. doi:10.1016/0735-1097(94)00557-7
Shimizu M, Umeda K, Sugihara N, Yoshio H, Ino H, Takeda R, Okada Y, Nakanishi I (1993) Collagen remodelling in myocardia of patients with diabetes. J Clin Pathol 46(1):32–36
Mizushige K, Yao L, Noma T, Kiyomoto H, Yu Y, Hosomi N, Ohmori K, Matsuo H (2000) Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin-resistant prediabetic stage of a type II diabetic rat model. Circulation 101(8):899–907
Westermann D, Rutschow S, Jager S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschope C (2007) Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism. Diabetes 56(3):641–646. doi:10.2337/db06-1163
Lawrence DA (1996) Transforming growth factor-beta: a general review. Eur Cytokine Netw 7(3):363–374
Bujak M, Frangogiannis NG (2007) The role of tgf-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 74(2):184–195. doi:10.1016/j.cardiores.2006.10.002
Hayashida T, Schnaper HW (2004) High ambient glucose enhances sensitivity to tgf-beta1 via extracellular signal–regulated kinase and protein kinase C delta activities in human mesangial cells. J Am Soc Nephrol 15(8):2032–2041. doi:10.1097/01.ASN.0000133198.74973.60
Lawler J (2002) Thrombospondin-1 as an endogenous inhibitor of angiogenesis and tumor growth. J Cell Mol Med 6(1):1–12. doi:10.1111/j.1582-4934.2002.tb00307.x
Meszaros JG, Gonzalez AM, Endo-Mochizuki Y, Villegas S, Villarreal F, Brunton LL (2000) Identification of g protein-coupled signaling pathways in cardiac fibroblasts: cross talk between g(q) and g(s). Am J Physiol Cell Physiol 278(1):C154–C162
Villarreal FJ, Kim NN, Ungab GD, Printz MP, Dillmann WH (1993) Identification of functional angiotensin ii receptors on rat cardiac fibroblasts. Circulation 88(6):2849–2861
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method. Methods 25(4):402–408
Han DC, Isono M, Hoffman BB, Ziyadeh FN (1999) High glucose stimulates proliferation and collagen type i synthesis in renal cortical fibroblasts: mediation by autocrine activation of tgf-beta. J Am Soc Nephrol 10(9):1891–1899
Tokudome T, Horio T, Yoshihara F, Suga S, Kawano Y, Kohno M, Kangawa K (2004) Direct effects of high glucose and insulin on protein synthesis in cultured cardiac myocytes and DNA and collagen synthesis in cardiac fibroblasts. Metabolism 53(6):710–715. doi:10.1016/j.metabol.2004.01.006
Wu D, Peng F, Zhang B, Ingram AJ, Kelly DJ, Gilbert RE, Gao B, Krepinsky JC (2009) Pkc-beta1 mediates glucose-induced akt activation and tgf-beta1 upregulation in mesangial cells. J Am Soc Nephrol 20(3):554–566. doi:10.1681/ASN.2008040445
Medcalf JF, Walls J, Pawluczyk IZ, Harris KP (2001) Effects of glucose dialysate on extracellular matrix production by human peritoneal mesothelial cells (hpmc): the role of tgf-beta. Nephrol Dial Transplant 16(9):1885–1892
Lam S, van der Geest RN, Verhagen NA, van Nieuwenhoven FA, Blom IE, Aten J, Goldschmeding R, Daha MR, van Kooten C (2003) Connective tissue growth factor and igf-i are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 52(12):2975–2983. doi:10.2337/diabetes.52.12.2975
Colwell AS, Faudoa R, Krummel TM, Longaker MT, Lorenz HP (2007) Transforming growth factor-beta, smad, and collagen expression patterns in fetal and adult keratinocytes. Plast Reconstr Surg 119:852–857. doi:10.1097/01.prs.0000255541.39993.66
Stratton R, Rajkumar V, Ponticos M, Nichols B, Shiwen X, Black CM, Abraham DJ, Leask A (2002) Prostacyclin derivatives prevent the fibrotic response to tgf-beta by inhibiting the ras/mek/erk pathway. Faseb J 16(14):1949–1951. doi:10.1096/fj.02-0204fje
Schiller M, Dennler S, Anderegg U, Kokot A, Simon JC, Luger TA, Mauviel A, Bohm M (2009) Increased camp levels modulate transforming growth factor(tgf-{beta})/smad-induced expression of extracellular matrix components and other key fibroblast effector functions. J Biol Chem 285(1):409–421. doi:10.1074/jbc.M109.038620
Murphy-Ullrich JE, Poczatek M (2000) Activation of latent tgf-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11(1–2):59–69
Bhattacharyya S, Marinic TE, Krukovets I, Hoppe G, Stenina OI (2008) Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose. J Biol Chem 283(9):5699–5707. doi:10.1074/jbc.M706435200
Poczatek MH, Hugo C, Darley-Usmar V, Murphy-Ullrich JE (2000) Glucose stimulation of transforming growth factor-beta bioactivity in mesangial cells is mediated by thrombospondin-1. Am J Pathol 157(4):1353–1363
Yung S, Lee CY, Zhang Q, Lau SK, Tsang RC, Chan TM (2006) Elevated glucose induction of thrombospondin-1 up-regulates fibronectin synthesis in proximal renal tubular epithelial cells through tgf-beta1 dependent and tgf-beta1 independent pathways. Nephrol Dial Transplant 21(6):1504–1513. doi:10.1093/ndt/gfl017
Belmadani S, Bernal J, Wei CC, Pallero MA, Dell’italia L, Murphy-Ullrich JE, Berecek KH (2007) A thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin ii. Am J Pathol 171(3):777–789. doi:10.2353/ajpath.2007.070056
Ribeiro SM, Poczatek M, Schultz-Cherry S, Villain M, Murphy-Ullrich JE (1999) The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-beta. J Biol Chem 274(19):13586–13593. doi:10.1074/jbc.274.19.13586
Schultz-Cherry S, Chen H, Mosher DF, Misenheimer TM, Krutzsch HC, Roberts DD, Murphy-Ullrich JE (1995) Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1. J Biol Chem 270(13):7304–7310. doi:10.1074/jbc.270.13.7304
Ihm SH, Chang K, Kim HY, Baek SH, Youn HJ, Seung KB, Kim JH (2010) Peroxisome proliferator-activated receptor-gamma activation attenuates cardiac fibrosis in type 2 diabetic rats: The effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor. Basic Res Cardiol 105(3):399–407. doi:10.1007/s00395-009-0071-x
Wang P, Li HW, Wang YP, Chen H, Zhang P (2009) Effects of recombinant human relaxin upon proliferation of cardiac fibroblast and synthesis of collagen under high glucose condition. J Endocrinol Invest 32(3):242–247
Singh VP, Baker KM, Kumar R (2008) Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: role in extracellular matrix production. Am J Physiol Heart Circ Physiol 294(4):H1675–H1684. doi:10.1152/ajpheart.91493.2007
Acknowledgments
This study was supported by the research grants from Key Technologies R & D Program of Shandong Province (2006GG2202020), the Independent Innovation Foundation of Shandong University (2009TS069), the National Natural Science Foundation of China (30670874, 30570748, 30871038, and 30971215), and the National Basic Research Program of China (973 Program, Grant no.: 2009CB521904).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Tang, M., Zhou, F., Zhang, W. et al. The role of thrombospondin-1-mediated TGF-β1 on collagen type III synthesis induced by high glucose. Mol Cell Biochem 346, 49–56 (2011). https://doi.org/10.1007/s11010-010-0590-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-010-0590-7